RT Journal Article
SR Electronic
T1 Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.08.09.21261669
DO 10.1101/2021.08.09.21261669
A1 Waldstein, Kody A.
A1 Yi, Jirong
A1 Cho, Michael Myung
A1 Mudumbai, Raghu
A1 Wu, Xiaodong
A1 Varga, Steven M.
A1 Xu, Weiyu
YR 2021
UL http://medrxiv.org/content/early/2021/08/10/2021.08.09.21261669.abstract
AB The rapid spread of SARS-CoV-2 has placed a significant burden on public health systems to provide rapid and accurate diagnostic testing highlighting the critical need for innovative testing approaches for future pandemics. In this study, we present a novel sample pooling procedure based on compressed sensing theory to accurately identify virally infected patients at high prevalence rates utilizing an innovative viral RNA extraction process to minimize sample dilution. At prevalence rates ranging from 0-14.3%, the number of tests required to identify the infection status of all patients was reduced by 75.6% as compared to conventional testing in primary human SARS-CoV-2 nasopharyngeal swabs and a coronavirus model system. Additionally, our modified pooling and RNA extraction process minimized sample dilution which remained constant as pool sizes increased. Our use of compressed sensing can be adapted to a wide variety of diagnostic testing applications to increase throughput for routine laboratory testing as well as a means to increase testing throughput to combat future pandemics.Competing Interest StatementWeiyu Xu, Xiaodong Wu, Jirong Yi, Raghuraman Mudumbai, and Myung Cho are the inventors of a pending patent with application number 17/387863 which is partially based on this work.Funding StatementThis work is funded by NSF under grant 2031218.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of Iowa Human Subjects Office/Institutional Review BoardAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe implementation of our system and the data used for conducting the experiments can be provided once requested.